Methodological critique reveals key limitations in diagnostic speed and cost analyses for cardiac implantable loop recorders, highlighting the need for rigorous evaluation.
Key Points
To re-evaluate the diagnostic speed, economic impact, and methodological limitations reported in the STAY-AWAY randomized trial of remote monitoring for cardiac implantable loop recorders.
Critically appraised the study design, diagnostic latency metrics, and cost outcomes from the randomized controlled STAY-AWAY trial.
Evaluated methodological constraints affecting remote monitoring protocols compared with standard in-clinic follow-up for cardiac rhythm evaluation.
Identified critical methodological limitations in trial endpoints measuring the speed of actionable cardiac arrhythmia detection.
Highlighted discrepancies and uncertainties regarding the cost-effectiveness and resource burden of continuous remote data transmission.